𝔖 Bobbio Scriptorium
✦   LIBER   ✦

EGFR gene amplification - rearrangement in human glioblastomas

✍ Scribed by Karl Schwechheimer; Su Huang; Webster K. Cavenee

Publisher
John Wiley and Sons
Year
1995
Tongue
French
Weight
516 KB
Volume
62
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Immunostaining using an affinity‐purified rabbit polyclonal antibody against the extracellular domain of the epidermal‐growth‐factor receptor (EGFR) showed over‐expression occurring in a fraction of tumor cells in 17 out of 18 human glioblastomas and in a majority of cells in 7 of the 18. Southern‐blotting technique using a full‐length EGFR cDNA probe showed a variable degree of amplification in 10 of the 17 glioblastomas, which was associated with EGFR over‐expression in each case. In 2 of the glioblastomas with EGFR gene amplification, a rearrangement of the gene affecting the extracellular domain of the receptor was identified and DNA sequence analyses revealed an identical deletion‐rearrangement of 801 base pairs between exons 2 to 7, resulting in an in‐frame fusion of exons I and 8. © 1995 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

3′ End structure and rearrangements of E
3′ End structure and rearrangements of EGFR in glioblastomas
✍ Greg Eley; Lori Frederick; Xiao-Yang Wang; David I. Smith; C. David James 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 1 views

Rearrangements of EGFR are known to occur in a significant fraction of glioblastomas, the most common and malignant form of central nervous system tumor. Although the consequences of these alterations have been described at the mRNA and protein level, little is known about human EGFR genomic sequenc

Gene amplification in human gliomas
Gene amplification in human gliomas
✍ Dr. V. P. Collins 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 994 KB

Gliomas represent the largest group of primary brain tumors in adults. The astrocytic variants are the most common and the adult forms are histologically stratified into three malignancy grades. Of these glioblastoma is the most common and the most malignant; it has also been best studied by molecul

MET gene amplification or EGFR mutation
MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors
✍ Takafumi Kubo; Hiromasa Yamamoto; William W. Lockwood; Ilse Valencia; Junichi So 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 315 KB

## Abstract We analyzed __MET__ protein and copy number in NSCLC with or without __EGFR__ mutations untreated with EGFR tyrosine kinase inhibitors (TKIs). __MET__ copy number was examined in 28 NSCLC and 4 human bronchial epithelial cell lines (HBEC) and 100 primary tumors using quantitative real‐t